Tri Femynor
- Product NDC
- 50090-3413
- 11-digit product format
- 500903413
- Labeler code
- 50090
- Product ID
- 50090-3413_75ef426b-d52e-482c-b264-64225a7937f1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- norgestimate and ethinyl estradiol
- Dosage form
- KIT
- Labeler
- A-S Medication Solutions
- Application
- ANDA203870
- Marketing category
- ANDA
- Marketing start
- 2016-10-28
- Marketing end
- 0000-00-00
- Active strength
- 0
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50090-3413-0 | 2023-01-30 | C162847 | 48780-1 | f386c64a-329d-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use TRI FEMYNOR safely and effectively. See full prescribing information for TRI FEMYNOR. TRI FEMYNORâ„¢ (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-3413-0 | Tri Femynor | 1 in 1 KIT | KIT | 1 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-3413 | TRI FEMYNOR (NORGESTIMATE AND ETHINYL ESTRADIOL) KIT [A-S MEDICATION SOLUTIONS] | 2 | Legacy NDC, 1 package rows | 20200122_0d754d53-2a8b-40c8-9008-64390cd72dd0.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1862600 | {7 (ethinyl estradiol 0.035 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Tri Femynor 28 Day] | BPCK | 0d754d53-2a8b-40c8-9008-64390cd72dd0 | 2 |
| 749784 | {7 (ethinyl estradiol 0.035 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack | GPCK | 0d754d53-2a8b-40c8-9008-64390cd72dd0 | 2 |
| 749784 | Eth estra-Norgestim 0.035-0.18 MG (7) Oral Tablet / Eth estra-Norgestim 0.035-0.215 MG (7) Oral Tablet / Eth estra-Norgestim 0.035-0.25 MG (7) Oral Tablet / Inert 1 MG (7) Oral Tablet 28 Day Pack | PSN | 0d754d53-2a8b-40c8-9008-64390cd72dd0 | 2 |
| 748797 | inert 1 MG Oral Tablet | PSN | 0d754d53-2a8b-40c8-9008-64390cd72dd0 | 2 |
| 406396 | norgestimate 0.18 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 0d754d53-2a8b-40c8-9008-64390cd72dd0 | 2 |
| 687424 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 0d754d53-2a8b-40c8-9008-64390cd72dd0 | 2 |
| 240128 | norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 0d754d53-2a8b-40c8-9008-64390cd72dd0 | 2 |
| 1862600 | Tri Femynor 28 Day Pack | PSN | 0d754d53-2a8b-40c8-9008-64390cd72dd0 | 2 |
| 406396 | ethinyl estradiol 0.035 MG / norgestimate 0.18 MG Oral Tablet | SCD | 0d754d53-2a8b-40c8-9008-64390cd72dd0 | 2 |
| 687424 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 0d754d53-2a8b-40c8-9008-64390cd72dd0 | 2 |
| 240128 | ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet | SCD | 0d754d53-2a8b-40c8-9008-64390cd72dd0 | 2 |
| 748797 | inert ingredients 1 MG Oral Tablet | SCD | 0d754d53-2a8b-40c8-9008-64390cd72dd0 | 2 |
| 240128 | ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet | SY | 0d754d53-2a8b-40c8-9008-64390cd72dd0 | 2 |
| 1862600 | Tri Femynor 28 Day Pack | SY | 0d754d53-2a8b-40c8-9008-64390cd72dd0 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50090-3413-0 | 50090341300 | 1 KIT in 1 KIT (50090-3413-0) | 1 kit | 2018-03-22 | 0000-00-00 | No | No | Current |